header-lab-new

Baby Genes, Inc. was formed in 2013 to fulfill an unmet need in the Newborn Screening (NBS) and Newborn Diagnostic arena. We are a Clinical Laboratory Improvement Act (CLIA) laboratory using Next Generation Sequencing (NGS) assays focused on reflex/diagnostic testing and supplemental newborn screening (NBS).

The Baby Genes mission is to save lives by providing parents, health care providers and public health departments a more standardized approach to NBS; one that screens for more conditions, is more responsive to current and future needs and provides more actionable information.

Our vision is a standard approach to screening newborns that does not allow a single child to suffer the ill-effects of genetic condition that is both identifiable and treatable from the very beginning. In addition, we want to see a world where the early detection of genetic conditions substantially improves an affected child’s quality of life.

Baby Genes Licensing

 
License Number
College of American Pathologists (CAP)
8131175
Clinical Laboratory Improvement Amendments (CLIA)
06D2084040
California State
COS-00800605
Pennsylvania State
34484
Rhode Island State
LCO00924
Florida State
800027873
Maryland State
2667
New York State
Pending

Baby Genes Tax Information

EIN
46-4079365
NPI
1336527365
DUNS
079232132

See also: